Abstract
Cannflavins, flavonoids abundantly present in Cannabis sativa, possess a distinct chemical structure comprising a vanillyl group. Notably, the capsaicin structure also contains a vanillyl group, which is considered essential for interacting with the vanilloid receptor. The vanilloid receptor plays a crucial role in the perception of pain, heat, and inflammation and mediates the analgesic effects of capsaicin. Therefore, we postulated that prolonged exposure to cannflavin A (Can A) and cannflavin B (Can B) would provoke vanilloid receptor desensitization and hinder nocifensive responses to noxious thermal stimuli. C. elegans wild-type (N2) and mutants were exposed to Can A and Can B solutions for 60 min and then aliquoted on Petri dishes divided into quadrants for thermal stimulation. We then determined the thermal avoidance index for each C. elegans experimental group. Proteomics was performed to identify proteins and pathways associated with Can A or B treatment. Prolonged exposure to Can A and Can B hindered heat avoidance (32-35 °C) in C. elegans. No antinociceptive effect was observed 6 h post Can A or B exposure. Proteomics and Reactome pathway enrichment analyses identified hierarchical differences between Can A- and B-treated nematodes. However, both treatments were related to eukaryotic translation initiation (R-CEL-72613) and metabolic processes strongly associated with pain development. Our study aids in characterizing the pharmacological activity of cannflavins isolated from Cannabis sativa and outlines a possible application as pain therapy.
Keywords: Caenorhabditis elegans, Cannabis sativa, Cannflavins, Nociception, Pain, Proteomics
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Abbas MA (2020) Modulation of TRPV1 channel function by natural products in the treatment of pain. Chem-biol Interact 330:109178. https://doi.org/10.1016/j.cbi.2020.109178 – DOI – PubMed
-
- Amin MR, Ali DW (2019) Pharmacology of medical cannabis. Adv Exp Med Biol 1162:151–165. https://doi.org/10.1007/978-3-030-21737-2_8 – DOI – PubMed
-
- Anand P, Bley K (2011) Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth 107:490–502. https://doi.org/10.1093/bja/aer260 – DOI – PubMed – PMC
-
- Baratta F, Pignata I, Enri LR, Brusa P (2022) Cannabis for medical use: analysis of recent clinical trials in view of current legislation. Front Pharmacol 13:888903. https://doi.org/10.3389/fphar.2022.888903 – DOI – PubMed – PMC
-
- Barrett ML, Scutt AM, Evans FJ (1986) Cannflavin A and B, prenylated flavones from Cannabis sativa L. Experientia 42:452–453. https://doi.org/10.1007/bf02118655 – DOI – PubMed